Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology- method. This study describes factors associated with women’s intentions to attend cervical cancer screening if high-risk HPV DNA testing (HPV-CCS) was implemented as a primary screening tool, and if screening were conducted every 4 years starting after age 25. Methods This online survey was designed using the Theory of Planned Behaviour to assess factors that impact women’s intentions to attend HPV-CCS among women aged 25–69 upon exit of the HPV FOCAL trial. Univariate and regression analyses were performed to compare the demographic, sexual history, and smoking characteristics betw...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Background Primary HPV cervical screening is due to be implemented in England within the next 2 yea...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screen...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervic...
Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cance...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of human papillomavirus (HPV) testing on women's intentions to be s...
Cervical cancer screening and prevention has been one of the great success stories in public health,...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Human papillomavirus (HPV) testing is recommended for primary screening for cervical cancer by sever...
Cervical cancer screening guidelines in the United States were revised in 2018 to include the option...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Background Primary HPV cervical screening is due to be implemented in England within the next 2 yea...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screen...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervic...
Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cance...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of human papillomavirus (HPV) testing on women's intentions to be s...
Cervical cancer screening and prevention has been one of the great success stories in public health,...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Human papillomavirus (HPV) testing is recommended for primary screening for cervical cancer by sever...
Cervical cancer screening guidelines in the United States were revised in 2018 to include the option...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Background Primary HPV cervical screening is due to be implemented in England within the next 2 yea...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...